3004.90 - Other:
Sub-classifications
-
3004 9092
-
3004 9092 01
-
-
-
3004 9092 02
-
-
3004 9092 04
-
3004 9092 06
-
-
-
3004 9092 08
-
3004 9092 12
-
-
3004 9092 13
-
3004 9092 14
-
-
3004 9092 15
-
-
3004 9092 16
-
3004 9092 17
-
3004 9092 18
-
3004 9092 19
-
3004 9092 21
-
-
-
-
3004 9092 22
-
3004 9092 23
-
3004 9092 25
-
-
3004 9092 27
-
3004 9092 29
-
-
-
3004 9092 31
-
3004 9092 32
-
-
3004 9092 33
-
3004 9092 34
-
-
3004 9092 36
-
-
3004 9092 37
-
3004 9092 38
-
3004 9092 39
-
-
3004 9092 40
-
-
-
3004 9092 42
-
3004 9092 44
-
-
-
3004 9092 50
-
3004 9092 55
-
3004 9092 56
-
3004 9092 57
-
3004 9092 59
-
-
-
-
3004 9092 63
-
3004 9092 66
-
3004 9092 68
-
-
3004 9092 70
-
-
-
3004 9092 76
-
-
3004 9092 80
-
3004 9092 84
-
3004 9092 89
-
-
-
3004 9092 91
-
-
Overview
This HTS category, 3004.90, encompasses "Other" medicaments not specifically classified under preceding subheadings within heading 3004. These are therapeutic or prophylactic preparations, in measured doses or retail packaging, that do not fall into the more specific categories like antibiotics, hormones, alkaloids, or vitamins. The core characteristic is that these medicaments contain active ingredients or combinations thereof that do not align with the exclusive compositional criteria of the sibling categories.
To classify goods under 3004.90, it is crucial to first examine the preceding subheadings. If a medicament contains penicillins or derivatives, antibiotics other than penicillins, hormones, alkaloids, or vitamins as its primary active component(s), it will be classified elsewhere. Only when the medicament's composition does not meet the specific criteria of these other subheadings does it become eligible for classification under 3004.90.
The subcategories under 3004.90 further refine the classification. 3004.90.10.00 specifically addresses medicaments containing antigens or hyaluronic acid or its sodium salt, representing distinct therapeutic uses. The remaining goods that do not fit these specific exclusions or inclusions are then directed to the residual category 3004.90.92, signifying a broad residual grouping for other medicaments meeting the general requirements of heading 3004.